Trending stocks today
Ishares Nasdaq Biotechnology (IBB-Q)
NASDAQ:IBB
133.99
0.85
(0.64%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 3 opinions in the last 12 months.
Experts express optimism over the IBB-Q Ishares Nasdaq Biotechnology fund, highlighting a trend of increased interest in biotech stocks amid declining interest rates. One expert emphasizes their preference for established pharmaceutical companies like AbbVie, suggesting that filling pipelines and reduced R&D costs could contribute to robust performance in this sector. There's a consensus that owning biotech is crucial, especially in light of potential changes in regulatory environments in Washington that could lessen regulatory burdens. The consensus highlights sensitivity to interest rates, with an overall positive sentiment that the sector's performance correlates favorably with falling rates, stimulating growth for companies engaged in lengthy R&D and trial phases.
He prefers to own individual names, but you need to own biotech, especially if there's a change in Washington (less regulation). It's very sensitive to interest rates, which will likely decline.
The sector has been up. It makes sense because biotechs do well as rates fall; these companies finance long-duration trials then marketing.
He bought this, expecting biotech to break out, but it's been deeply disappointing. It hasn't worked yet.
Healthcare sector outlook The sector has had a great bounce since March lows. A good way to play the COVID vaccine race. IBB is the best-known biotech ETF, but he does the XBI, because it's equal-weighted. XBI has had a great bounce. It's a great sector with reasonable valuations. The race for a COVID vaccine is a tailwind, of course. Biotech is a slow-growth area, which benefit from interest rates staying very low for the long term.
Ishares Nasdaq Biotechnology(IBB-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 3
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 3
Ishares Nasdaq Biotechnology(IBB-Q) Frequently Asked Questions
What is Ishares Nasdaq Biotechnology stock symbol?
Ishares Nasdaq Biotechnology is a American stock, trading under the symbol IBB-Q on the NASDAQ (IBB). It is usually referred to as NASDAQ:IBB or IBB-Q
Is Ishares Nasdaq Biotechnology a buy or a sell?
In the last year, 3 stock analysts published opinions about IBB-Q. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Ishares Nasdaq Biotechnology.
Is Ishares Nasdaq Biotechnology a good investment or a top pick?
Ishares Nasdaq Biotechnology was recommended as a Top Pick by on . Read the latest stock experts ratings for Ishares Nasdaq Biotechnology.
Why is Ishares Nasdaq Biotechnology stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Ishares Nasdaq Biotechnology worth watching?
3 stock analysts on Stockchase covered Ishares Nasdaq Biotechnology In the last year. It is a trending stock that is worth watching.
What is Ishares Nasdaq Biotechnology stock price?
On 2025-03-14, Ishares Nasdaq Biotechnology (IBB-Q) stock closed at a price of $133.99.
He likes big pharma with AbbVie his favourite name. Pipelines are starting to fill, and if rates hold and R&D gets cheaper, these stocks will continue to work.